CTMX-2018-09-30-10-Q

Company

CytomX Therapeutics, Inc.

Filed

November 6, 2018

Period of Report

September 30, 2018

Accession Number

0001564590-18-027387

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →